{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:05:42Z","timestamp":1790996742003,"version":"4.1.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s10495-010-0486-8","type":"journal-article","created":{"date-parts":[[2010,3,9]],"date-time":"2010-03-09T12:16:37Z","timestamp":1268136997000},"page":"1312-1321","source":"Crossref","is-referenced-by-count":45,"title":["The regulatory role of \u03b1-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Toru","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"key":"486_CR1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrg1831","volume":"7","author":"MJ Farrer","year":"2006","unstructured":"Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7:306\u2013318","journal-title":"Nat Rev Genet"},{"key":"486_CR2","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","volume":"103","author":"CW Shults","year":"2006","unstructured":"Shults CW (2006) Lewy bodies. Proc Natl Acad Sci USA 103:1661\u20131668","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR3","doi-asserted-by":"crossref","first-page":"S613","DOI":"10.1002\/mds.22061","volume":"23","author":"CW Olanow","year":"2008","unstructured":"Olanow CW (2008) Levodopa\/dopamine replacement strategies in Parkinson\u2019s disease\u2013future directions. Mov Disord 23:S613\u2013S622","journal-title":"Mov Disord"},{"key":"486_CR4","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","volume":"3","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Brundin P (2002) Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3:932\u2013942","journal-title":"Nat Rev Neurosci"},{"key":"486_CR5","doi-asserted-by":"crossref","first-page":"24065","DOI":"10.1074\/jbc.M002413200","volume":"275","author":"CA da Costa","year":"2000","unstructured":"da Costa CA, Ancolio K, Checler F (2000) Wild-type but not Parkinson\u2019s disease-related ala-53\u2192 Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli. J Biol Chem 275:24065\u201324069","journal-title":"J Biol Chem"},{"key":"486_CR6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","volume":"8","author":"J Xu","year":"2002","unstructured":"Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 8:600\u2013606","journal-title":"Nat Med"},{"key":"486_CR7","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","volume":"26","author":"Y Leng","year":"2006","unstructured":"Leng Y, Chuang DM (2006) Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J Neurosci 26:7502\u20137512","journal-title":"J Neurosci"},{"key":"486_CR8","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"KA Conway","year":"2001","unstructured":"Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294:1346\u20131349","journal-title":"Science"},{"key":"486_CR9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","volume":"91","author":"M Yamada","year":"2004","unstructured":"Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H (2004) Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease. J Neurochem 91:451\u2013461","journal-title":"J Neurochem"},{"key":"486_CR10","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1471-4159.2008.05827.x","volume":"108","author":"T Yasuda","year":"2009","unstructured":"Yasuda T, Nihira T, Ren YR et al (2009) Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson\u2019s disease. J Neurochem 108:932\u2013944","journal-title":"J Neurochem"},{"key":"486_CR11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 392:605\u2013608","journal-title":"Nature"},{"key":"486_CR12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/WNL.44.3_Part_1.437","volume":"44","author":"H Takahashi","year":"1994","unstructured":"Takahashi H, Ohama E, Suzuki S, Horikawa Y, Ishikawa A, Morita T, Tsuji S, Ikuta F (1994) Familial juvenile Parkinsonism: clinical and pathologic study in a family. Neurology 44:437\u2013441","journal-title":"Neurology"},{"key":"486_CR13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.51.3.890","volume":"51","author":"H Mori","year":"1998","unstructured":"Mori H, Kondo T, Yokochi M, Matsumine H, Nakagawa-Hattori Y, Miyake T, Suda K, Mizuno Y (1998) Pathologic and biochemical studies of juvenile Parkinsonism linked to chromosome 6q. Neurology 51:890\u2013892","journal-title":"Neurology"},{"key":"486_CR14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8","volume":"15","author":"S Hayashi","year":"2000","unstructured":"Hayashi S, Wakabayashi K, Ishikawa A et al (2000) An autopsy case of autosomal-recessive juvenile Parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord 15:884\u2013888","journal-title":"Mov Disord"},{"key":"486_CR15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1212\/WNL.56.4.555","volume":"56","author":"BP Warrenburg van de","year":"2001","unstructured":"van de Warrenburg BP, Lammens M, Lucking CB et al (2001) Clinical and pathologic abnormalities in a family with Parkinsonism and parkin gene mutations. Neurology 56:555\u2013557","journal-title":"Neurology"},{"key":"486_CR16","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt JM, Dawson VL, Dawson TM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 116:1744\u20131754","journal-title":"J Clin Invest"},{"key":"486_CR17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","volume":"25","author":"H Shimura","year":"2000","unstructured":"Shimura H, Hattori N, Kubo S et al (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25:302\u2013305","journal-title":"Nat Genet"},{"key":"486_CR18","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.1093891","volume":"304","author":"KK Chung","year":"2004","unstructured":"Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, Dawson TM (2004) S-nitrosylation of parkin regulates ubiquitination and compromises parkin\u2019s protective function. Science 304:1328\u20131331","journal-title":"Science"},{"key":"486_CR19","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1073\/pnas.0404161101","volume":"101","author":"D Yao","year":"2004","unstructured":"Yao D, Gu Z, Nakamura T et al (2004) Nitrosative stress linked to sporadic Parkinson\u2019s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci USA 101:10810\u201310814","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR20","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm1314","volume":"11","author":"MJ LaVoie","year":"2005","unstructured":"LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ (2005) Dopamine covalently modifies and functionally inactivates parkin. Nat Med 11:1214\u20131221","journal-title":"Nat Med"},{"key":"486_CR21","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1523\/JNEUROSCI.4474-04.2005","volume":"25","author":"KL Lim","year":"2005","unstructured":"Lim KL, Chew KC, Tan JM et al (2005) Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J Neurosci 25:2002\u20132009","journal-title":"J Neurosci"},{"key":"486_CR22","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1074\/jbc.M413591200","volume":"280","author":"EW Doss-Pepe","year":"2005","unstructured":"Doss-Pepe EW, Chen L, Madura K (2005) Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains. J Biol Chem 280:16619\u201316624","journal-title":"J Biol Chem"},{"key":"486_CR23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.neurobiolaging.2005.07.023","volume":"27","author":"KL Lim","year":"2006","unstructured":"Lim KL, Dawson VL, Dawson TM (2006) Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson\u2019s and other conformational diseases? Neurobiol Aging 27:524\u2013529","journal-title":"Neurobiol Aging"},{"key":"486_CR24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1126\/science.1127085","volume":"315","author":"D Mukhopadhyay","year":"2007","unstructured":"Mukhopadhyay D, Riezman H (2007) Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315:201\u2013205","journal-title":"Science"},{"key":"486_CR25","doi-asserted-by":"crossref","first-page":"43628","DOI":"10.1074\/jbc.M308947200","volume":"278","author":"MS Goldberg","year":"2003","unstructured":"Goldberg MS, Fleming SM, Palacino JJ et al (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278:43628\u201343635","journal-title":"J Biol Chem"},{"key":"486_CR26","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/hmg\/ddg239","volume":"12","author":"JM Itier","year":"2003","unstructured":"Itier JM, Ibanez P, Mena MA et al (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12:2277\u20132291","journal-title":"Hum Mol Genet"},{"key":"486_CR27","doi-asserted-by":"crossref","first-page":"10744","DOI":"10.1073\/pnas.0401297101","volume":"101","author":"R Coelln von","year":"2004","unstructured":"von Coelln R, Thomas B, Savitt JM, Lim KL, Sasaki M, Hess EJ, Dawson VL, Dawson TM (2004) Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci USA 101:10744\u201310749","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR28","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1073\/pnas.0409598102","volume":"102","author":"FA Perez","year":"2005","unstructured":"Perez FA, Palmiter RD (2005) Parkin-deficient mice are not a robust model of Parkinsonism. Proc Natl Acad Sci USA 102:2174\u20132179","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR29","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279:18614\u201318622","journal-title":"J Biol Chem"},{"key":"486_CR30","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.1523\/JNEUROSCI.3001-08.2008","volume":"28","author":"TC Frank-Cannon","year":"2008","unstructured":"Frank-Cannon TC, Tran T, Ruhn KA et al (2008) Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J Neurosci 28:10825\u201310834","journal-title":"J Neurosci"},{"key":"486_CR31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","volume":"441","author":"J Park","year":"2006","unstructured":"Park J, Lee SB, Lee S et al (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441:1157\u20131161","journal-title":"Nature"},{"key":"486_CR32","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","volume":"441","author":"IE Clark","year":"2006","unstructured":"Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:1162\u20131166","journal-title":"Nature"},{"key":"486_CR33","doi-asserted-by":"crossref","first-page":"10793","DOI":"10.1073\/pnas.0602493103","volume":"103","author":"Y Yang","year":"2006","unstructured":"Yang Y, Gehrke S, Imai Y et al (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA 103:10793\u201310798","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR34","doi-asserted-by":"crossref","first-page":"11257","DOI":"10.1523\/JNEUROSCI.2375-09.2009","volume":"29","author":"CH Ng","year":"2009","unstructured":"Ng CH, Mok SZ, Koh C et al (2009) Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila. J Neurosci 29:11257\u201311262","journal-title":"J Neurosci"},{"key":"486_CR35","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ymthe.2006.06.009","volume":"14","author":"L Vercammen","year":"2006","unstructured":"Vercammen L, Van der Perren A, Vaudano E, Gijsbers R, Debyser Z, Van den Haute C, Baekelandt V (2006) Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson\u2019s disease. Mol Ther 14:716\u2013723","journal-title":"Mol Ther"},{"key":"486_CR36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/sj.mt.6300154","volume":"15","author":"JC Paterna","year":"2007","unstructured":"Paterna JC, Leng A, Weber E, Feldon J, Bueler H (2007) DJ-1 and parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther 15:698\u2013704","journal-title":"Mol Ther"},{"key":"486_CR37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/hum.2005.16.262","volume":"16","author":"M Yamada","year":"2005","unstructured":"Yamada M, Mizuno Y, Mochizuki H (2005) Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson\u2019s disease. Hum Gene Ther 16:262\u2013270","journal-title":"Hum Gene Ther"},{"key":"486_CR38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuroscience.2006.09.052","volume":"144","author":"T Yasuda","year":"2007","unstructured":"Yasuda T, Miyachi S, Kitagawa R et al (2007) Neuronal specificity of alpha-synuclein toxicity and effect of parkin co-expression in primates. Neuroscience 144:743\u2013753","journal-title":"Neuroscience"},{"key":"486_CR39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1586\/14737175.7.8.957","volume":"7","author":"H Mochizuki","year":"2007","unstructured":"Mochizuki H (2007) Gene therapy for Parkinson\u2019s disease. Expert Rev Neurother 7:957\u2013960","journal-title":"Expert Rev Neurother"},{"key":"486_CR40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.nurt.2008.01.005","volume":"5","author":"H Mochizuki","year":"2008","unstructured":"Mochizuki H, Yasuda T, Mouradian MM (2008) Advances in gene therapy for movement disorders. Neurotherapeutics 5:260\u2013269","journal-title":"Neurotherapeutics"},{"key":"486_CR41","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S1353-8020(09)70012-4","volume":"15","author":"H Mochizuki","year":"2009","unstructured":"Mochizuki H (2009) Parkin gene therapy. Parkinsonism Relat Disord 15:S43\u2013S45","journal-title":"Parkinsonism Relat Disord"},{"key":"486_CR42","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1582-4934.2008.00402.x","volume":"12","author":"AM Gorman","year":"2008","unstructured":"Gorman AM (2008) Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med 12:2263\u20132280","journal-title":"J Cell Mol Med"},{"key":"486_CR43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F","volume":"14","author":"EC Hirsch","year":"1999","unstructured":"Hirsch EC, Hunot S, Faucheux B, Agid Y, Mizuno Y, Mochizuki H, Tatton WG, Tatton N, Olanow WC (1999) Dopaminergic neurons degenerate by apoptosis in Parkinson\u2019s disease. Mov Disord 14:383\u2013385","journal-title":"Mov Disord"},{"key":"486_CR44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn1100","volume":"4","author":"M Vila","year":"2003","unstructured":"Vila M, Przedborski S (2003) Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci 4:365\u2013375","journal-title":"Nat Rev Neurosci"},{"key":"486_CR45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"486_CR46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0022-510X(95)00336-Z","volume":"137","author":"H Mochizuki","year":"1996","unstructured":"Mochizuki H, Goto K, Mori H, Mizuno Y (1996) Histochemical detection of apoptosis in Parkinson\u2019s disease. J Neurol Sci 137:120\u2013123","journal-title":"J Neurol Sci"},{"key":"486_CR47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-7091-6842-4_13","volume":"50","author":"H Mochizuki","year":"1997","unstructured":"Mochizuki H, Mori H, Mizuno Y (1997) Apoptosis in neurodegenerative disorders. J Neural Transm Suppl 50:125\u2013140","journal-title":"J Neural Transm Suppl"},{"key":"486_CR48","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1002\/ana.410440721","volume":"44","author":"NA Tatton","year":"1998","unstructured":"Tatton NA, Maclean-Fraser A, Tatton WG, Perl DP, Olanow CW (1998) A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson\u2019s disease. Ann Neurol 44:S142\u2013S148","journal-title":"Ann Neurol"},{"key":"486_CR49","first-page":"25","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade P, Vyas S, Javoy-Agid F (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histol Histopathol 12:25\u201331","journal-title":"Histol Histopathol"},{"key":"486_CR50","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1073\/pnas.040556597","volume":"97","author":"A Hartmann","year":"2000","unstructured":"Hartmann A, Hunot S, Michel PP (2000) Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease. Proc Natl Acad Sci USA 97:2875\u20132880","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR51","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1073\/pnas.191107398","volume":"98","author":"H Mochizuki","year":"2001","unstructured":"Mochizuki H, Hayakawa H, Migita M et al (2001) An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson\u2019s disease. Proc Natl Acad Sci USA 98:10918\u201310923","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR52","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.051633998","volume":"98","author":"M Vila","year":"2001","unstructured":"Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S (2001) Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 98:2837\u20132842","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR53","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0609874104","volume":"104","author":"C Perier","year":"2007","unstructured":"Perier C, Bove J, Wu DC et al (2007) Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson\u2019s disease. Proc Natl Acad Sci USA 104:8161\u20138166","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR54","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"486_CR55","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108","journal-title":"Nat Genet"},{"key":"486_CR56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC et al (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164\u2013173","journal-title":"Ann Neurol"},{"key":"486_CR57","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J et al (2003) Alpha-synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841","journal-title":"Science"},{"key":"486_CR58","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.20753","volume":"59","author":"K Nishioka","year":"2006","unstructured":"Nishioka K, Hayashi S, Farrer MJ et al (2006) Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson\u2019s disease. Ann Neurol 59:298\u2013309","journal-title":"Ann Neurol"},{"key":"486_CR59","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/hmg\/10.17.1847","volume":"10","author":"M Farrer","year":"2001","unstructured":"Farrer M, Maraganore DM, Lockhart P et al (2001) Alpha-synuclein gene haplotypes are associated with Parkinson\u2019s disease. Hum Mol Genet 10:1847\u20131851","journal-title":"Hum Mol Genet"},{"key":"486_CR60","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","volume":"28","author":"HM Gao","year":"2008","unstructured":"Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VM (2008) Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci 28:7687\u20137698","journal-title":"J Neurosci"},{"key":"486_CR61","doi-asserted-by":"crossref","first-page":"49071","DOI":"10.1074\/jbc.M208046200","volume":"277","author":"M Hasegawa","year":"2002","unstructured":"Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VM, Trojanowski JQ, Mann D, Iwatsubo T (2002) Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J Biol Chem 277:49071\u201349076","journal-title":"J Biol Chem"},{"key":"486_CR62","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","volume":"102","author":"W Li","year":"2005","unstructured":"Li W, West N, Colla E et al (2005) Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations. Proc Natl Acad Sci USA 102:2162\u20132167","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR63","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb841","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164","journal-title":"Nat Cell Biol"},{"key":"486_CR64","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1523\/JNEUROSCI.0482-05.2005","volume":"25","author":"WW Smith","year":"2005","unstructured":"Smith WW, Margolis RL, Li X, Troncoso JC, Lee MK, Dawson VL, Dawson TM, Iwatsubo T, Ross CA (2005) Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. J Neurosci 25:5544\u20135552","journal-title":"J Neurosci"},{"key":"486_CR65","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nn1443","volume":"8","author":"L Chen","year":"2005","unstructured":"Chen L, Feany MB (2005) Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8:657\u2013663","journal-title":"Nat Neurosci"},{"key":"486_CR66","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.0711053105","volume":"105","author":"OS Gorbatyuk","year":"2008","unstructured":"Gorbatyuk OS, Li S, Sullivan LF, Chen W, Kondrikova G, Manfredsson FP, Mandel RJ, Muzyczka N (2008) The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc Natl Acad Sci USA 105:763\u2013768","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/NEN.0b013e3181a24b53","volume":"68","author":"NR McFarland","year":"2009","unstructured":"McFarland NR, Fan Z, Xu K, Schwarzschild MA, Feany MB, Hyman BT, McLean PJ (2009) Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease. J Neuropathol Exp Neurol 68:515\u2013524","journal-title":"J Neuropathol Exp Neurol"},{"key":"486_CR68","first-page":"872","volume":"18","author":"S Azeredo da Silveira","year":"2009","unstructured":"Azeredo da Silveira S, Schneider BL, Cifuentes-Diaz C, Sage D, Abbas-Terki T, Iwatsubo T, Unser M, Aebischer P (2009) Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson\u2019s disease. Hum Mol Genet 18:872\u2013887","journal-title":"Hum Mol Genet"},{"key":"486_CR69","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/hmg\/9.18.2683","volume":"9","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi SJ, Orth M, Wilkinson JM, Taanman JW, Warner TT, Cooper JM, Schapira AH (2000) Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity. Hum Mol Genet 9:2683\u20132689","journal-title":"Hum Mol Genet"},{"key":"486_CR70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-8993(00)02215-0","volume":"866","author":"W Zhou","year":"2000","unstructured":"Zhou W, Hurlbert MS, Schaack J, Prasad KN, Freed CR (2000) Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res 866:33\u201343","journal-title":"Brain Res"},{"key":"486_CR71","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0304-3940(02)00016-2","volume":"320","author":"E Junn","year":"2002","unstructured":"Junn E, Mouradian MM (2002) Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Neurosci Lett 320:146\u2013150","journal-title":"Neurosci Lett"},{"key":"486_CR72","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1096\/fj.02-0041fje","volume":"16","author":"JH Seo","year":"2002","unstructured":"Seo JH, Rah JC, Choi SH et al (2002) Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3\/Akt kinase pathway. FASEB J 16:1826\u20131828","journal-title":"FASEB J"},{"key":"486_CR73","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2005.04.124","volume":"332","author":"Y Machida","year":"2005","unstructured":"Machida Y, Chiba T, Takayanagi A et al (2005) Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells. Biochem Biophys Res Commun 332:233\u2013240","journal-title":"Biochem Biophys Res Commun"},{"key":"486_CR74","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","volume":"19","author":"N Ostrerova","year":"1999","unstructured":"Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J, Wolozin B (1999) Alpha-synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci 19:5782\u20135791","journal-title":"J Neurosci"},{"key":"486_CR75","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/8820","volume":"22","author":"S Engelender","year":"1999","unstructured":"Engelender S, Kaminsky Z, Guo X et al (1999) Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet 22:110\u2013114","journal-title":"Nat Genet"},{"key":"486_CR76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0169-328X(02)00510-7","volume":"108","author":"A Ubl","year":"2002","unstructured":"Ubl A, Berg D, Holzmann C, Kruger R, Berger K, Arzberger T, Bornemann A, Riess O (2002) 14-3-3 protein is a component of Lewy bodies in Parkinson\u2019s disease-mutation analysis and association studies of 14-3-3 eta. Brain Res Mol Brain Res 108:33\u201339","journal-title":"Brain Res Mol Brain Res"},{"key":"486_CR77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnen\/61.3.245","volume":"61","author":"Y Kawamoto","year":"2002","unstructured":"Kawamoto Y, Akiguchi I, Nakamura S, Honjyo Y, Shibasaki H, Budka H (2002) 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol 61:245\u2013253","journal-title":"J Neuropathol Exp Neurol"},{"key":"486_CR78","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s004010100451","volume":"103","author":"K Wakabayashi","year":"2002","unstructured":"Wakabayashi K, Engelender S, Tanaka Y, Yoshimoto M, Mori F, Tsuji S, Ross CA, Takahashi H (2002) Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol 103:209\u2013214","journal-title":"Acta Neuropathol"},{"key":"486_CR79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","volume":"91","author":"SR Datta","year":"1997","unstructured":"Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231\u2013241","journal-title":"Cell"},{"key":"486_CR80","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","volume":"96","author":"A Brunet","year":"1999","unstructured":"Brunet A, Bonni A, Zigmond MJ et al (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857\u2013868","journal-title":"Cell"},{"key":"486_CR81","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nm0602-564","volume":"8","author":"K Welch","year":"2002","unstructured":"Welch K, Yuan J (2002) Releasing the nerve cell killers. Nat Med 8:564\u2013565","journal-title":"Nat Med"},{"key":"486_CR82","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1074\/jbc.M310994200","volume":"279","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Kim YM, Lee G, Junn E, Iwatsubo T, Mouradian MM (2004) Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J Biol Chem 279:4625\u20134631","journal-title":"J Biol Chem"},{"key":"486_CR83","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1073\/pnas.0509707103","volume":"103","author":"A Eyal","year":"2006","unstructured":"Eyal A, Szargel R, Avraham E, Liani E, Haskin J, Rott R, Engelender S (2006) Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients. Proc Natl Acad Sci USA 103:5917\u20135922","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR84","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/hmg\/ddg134","volume":"12","author":"FP Marx","year":"2003","unstructured":"Marx FP, Holzmann C, Strauss KM et al (2003) Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson\u2019s disease. Hum Mol Genet 12:1223\u20131231","journal-title":"Hum Mol Genet"},{"key":"486_CR85","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265\u20131269","journal-title":"Science"},{"key":"486_CR86","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","volume":"20","author":"H Putten van der","year":"2000","unstructured":"van der Putten H, Wiederhold KH, Probst A et al (2000) Neuropathology in mice expressing human alpha-synuclein. J Neurosci 20:6021\u20136029","journal-title":"J Neurosci"},{"key":"486_CR87","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","volume":"8","author":"Y Matsuoka","year":"2001","unstructured":"Matsuoka Y, Vila M, Lincoln S et al (2001) Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis 8:535\u2013539","journal-title":"Neurobiol Dis"},{"key":"486_CR88","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34:521\u2013533","journal-title":"Neuron"},{"key":"486_CR89","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee MK, Stirling W, Xu Y et al (2002) Human alpha-synuclein-harbouring familial Parkinson\u2019s disease-linked Ala-53\u00a0>\u00a0Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 99:8968\u20138973","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR90","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","volume":"110","author":"M Neumann","year":"2002","unstructured":"Neumann M, Kahle PJ, Giasson BI et al (2002) Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest 110:1429\u20131439","journal-title":"J Clin Invest"},{"key":"486_CR91","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.2002.7882","volume":"175","author":"EK Richfield","year":"2002","unstructured":"Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ (2002) Behavioural and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp Neurol 175:35\u201348","journal-title":"Exp Neurol"},{"key":"486_CR92","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","volume":"68","author":"E Rockenstein","year":"2002","unstructured":"Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, Masliah E (2002) Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 68:568\u2013578","journal-title":"J Neurosci Res"},{"key":"486_CR93","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1044-7431(03)00198-2","volume":"24","author":"S Gispert","year":"2003","unstructured":"Gispert S, Del Turco D, Garrett L et al (2003) Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci 24:419\u2013429","journal-title":"Mol Cell Neurosci"},{"key":"486_CR94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.2003.tb07475.x","volume":"991","author":"M Hashimoto","year":"2003","unstructured":"Hashimoto M, Rockenstein E, Masliah E (2003) Transgenic models of alpha-synuclein pathology: past, present, and future. Ann NY Acad Sci 991:171\u2013188","journal-title":"Ann NY Acad Sci"},{"key":"486_CR95","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","volume":"26","author":"LJ Martin","year":"2006","unstructured":"Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, Lee MK (2006) Parkinson\u2019s disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26:41\u201350","journal-title":"J Neurosci"},{"key":"486_CR96","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","volume":"46","author":"E Masliah","year":"2005","unstructured":"Masliah E, Rockenstein E, Adame A et al (2005) Effects of alpha-synuclein immunization in a mouse model of Parkinson\u2019s disease. Neuron 46:857\u2013868","journal-title":"Neuron"},{"key":"486_CR97","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.gt.3302349","volume":"11","author":"M Hashimoto","year":"2004","unstructured":"Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, Gage FH, Marr R, Masliah E (2004) An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model. Gene Ther 11:1713\u20131723","journal-title":"Gene Ther"},{"key":"486_CR98","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","volume":"29","author":"B Spencer","year":"2009","unstructured":"Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R, Adame A, Wyss-Coray T, Masliah E (2009) Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson\u2019s and Lewy body diseases. J Neurosci 29:13578\u201313588","journal-title":"J Neurosci"},{"key":"486_CR99","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","volume":"186","author":"DD Song","year":"2004","unstructured":"Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186:158\u2013172","journal-title":"Exp Neurol"},{"key":"486_CR100","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","volume":"99","author":"W Dauer","year":"2002","unstructured":"Dauer W, Kholodilov N, Vila M (2002) Resistance of alpha -synuclein null mice to the Parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA 99:14524\u201314529","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR101","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","volume":"22","author":"D Kirik","year":"2002","unstructured":"Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ, Bjorklund A (2002) Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci 22:2780\u20132791","journal-title":"J Neurosci"},{"key":"486_CR102","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/10430340252837206","volume":"13","author":"RL Klein","year":"2002","unstructured":"Klein RL, King MA, Hamby ME, Meyer EM (2002) Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Hum Gene Ther 13:605\u2013612","journal-title":"Hum Gene Ther"},{"key":"486_CR103","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","volume":"99","author":"C Lo Bianco","year":"2002","unstructured":"Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P (2002) Alpha-synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 99:10813\u201310818","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR104","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1750-3639.2003.tb00035.x","volume":"13","author":"E Lauwers","year":"2003","unstructured":"Lauwers E, Debyser Z, Van Dorpe J, De Strooper B, Nuttin B, Baekelandt V (2003) Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein. Brain Pathol 13:364\u2013372","journal-title":"Brain Pathol"},{"key":"486_CR105","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","volume":"100","author":"D Kirik","year":"2003","unstructured":"Kirik D, Annett LE, Burger C, Muzyczka N, Mandel RJ, Bjorklund A (2003) Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 100:2884\u20132889","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR106","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14:504\u2013506","journal-title":"Nat Med"},{"key":"486_CR107","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/mds.22369","volume":"23","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB (2008) Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 23:2303\u20132306","journal-title":"Mov Disord"},{"key":"486_CR108","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 14:501\u2013503","journal-title":"Nat Med"},{"key":"486_CR109","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106:13010\u201313015","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR110","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jnen\/63.11.1155","volume":"63","author":"B Winner","year":"2004","unstructured":"Winner B, Lie DC, Rockenstein E, Aigner R, Aigner L, Masliah E, Kuhn HG, Winkler J (2004) Human wild-type alpha-synuclein impairs neurogenesis. J Neuropathol Exp Neurol 63:1155\u20131166","journal-title":"J Neuropathol Exp Neurol"},{"key":"486_CR111","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.0066-08.2008","volume":"28","author":"L Crews","year":"2008","unstructured":"Crews L, Mizuno H, Desplats P, Rockenstein E, Adame A, Patrick C, Winner B, Winkler J, Masliah E (2008) Alpha-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice. J Neurosci 28:4250\u20134260","journal-title":"J Neurosci"},{"key":"486_CR112","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1460-9568.2009.06641.x","volume":"29","author":"F Marxreiter","year":"2009","unstructured":"Marxreiter F, Nuber S, Kandasamy M et al (2009) Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein. Eur J Neurosci 29:879\u2013890","journal-title":"Eur J Neurosci"},{"key":"486_CR113","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/NEN.0b013e31818b4126","volume":"67","author":"R Sengoku","year":"2008","unstructured":"Sengoku R, Saito Y, Ikemura M et al (2008) Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 67:1072\u20131083","journal-title":"J Neuropathol Exp Neurol"},{"key":"486_CR114","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","volume":"63","author":"GW Ross","year":"2008","unstructured":"Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR (2008) Association of olfactory dysfunction with risk for future Parkinson\u2019s disease. Ann Neurol 63:167\u2013173","journal-title":"Ann Neurol"},{"key":"486_CR115","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/mds.22534","volume":"24","author":"MM Ponsen","year":"2009","unstructured":"Ponsen MM, Stoffers D, Twisk JW, Wolters ECh, Berendse HW (2009) Hyposmia and executive dysfunction as predictors of future Parkinson\u2019s disease: a prospective study. Mov Disord 24:1060\u20131065","journal-title":"Mov Disord"},{"key":"486_CR116","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ana.10524","volume":"53","author":"SA Oliveira","year":"2003","unstructured":"Oliveira SA, Scott WK, Martin ER et al (2003) Parkin mutations and susceptibility alleles in late-onset Parkinson\u2019s disease. Ann Neurol 53:624\u2013629","journal-title":"Ann Neurol"},{"key":"486_CR117","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0387-7604(00)00130-3","volume":"22","author":"Y Yamamura","year":"2000","unstructured":"Yamamura Y, Hattori N, Matsumine H, Kuzuhara S, Mizuno Y (2000) Autosomal recessive early-onset Parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification. Brain Dev 22:S87\u2013S91","journal-title":"Brain Dev"},{"key":"486_CR118","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)61113-3","volume":"160","author":"MG Schlossmacher","year":"2002","unstructured":"Schlossmacher MG, Frosch MP, Gai WP et al (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol 160:1655\u20131667","journal-title":"Am J Pathol"},{"key":"486_CR119","doi-asserted-by":"crossref","first-page":"12842","DOI":"10.1074\/jbc.M608243200","volume":"282","author":"E Avraham","year":"2007","unstructured":"Avraham E, Rott R, Liani E, Szargel R, Engelender S (2007) Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. J Biol Chem 282:12842\u201312850","journal-title":"J Biol Chem"},{"key":"486_CR120","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbrc.2008.10.104","volume":"377","author":"Y Kim","year":"2008","unstructured":"Kim Y, Park J, Kim S, Song S, Kwon SK, Lee SH, Kitada T, Kim JM, Chung J (2008) PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun 377:975\u2013980","journal-title":"Biochem Biophys Res Commun"},{"key":"486_CR121","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/hmg\/ddp501","volume":"19","author":"D Sha","year":"2010","unstructured":"Sha D, Chin LS, Li L (2010) Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum Mol Genet 19:352\u2013363","journal-title":"Hum Mol Genet"},{"key":"486_CR122","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.neuron.2004.11.026","volume":"44","author":"SK Kalia","year":"2004","unstructured":"Kalia SK, Lee S, Smith PD et al (2004) BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron 44:931\u2013945","journal-title":"Neuron"},{"key":"486_CR123","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm1001-1144","volume":"7","author":"KK Chung","year":"2001","unstructured":"Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 7:1144\u20131150","journal-title":"Nat Med"},{"key":"486_CR124","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nm1001-1108","volume":"7","author":"A Ciechanover","year":"2001","unstructured":"Ciechanover A (2001) Linking ubiquitin, parkin and synphilin-1. Nat Med 7:1108\u20131109","journal-title":"Nat Med"},{"key":"486_CR125","doi-asserted-by":"crossref","first-page":"47870","DOI":"10.1074\/jbc.M203159200","volume":"277","author":"E Junn","year":"2002","unstructured":"Junn E, Lee SS, Suhr UT, Mouradian MM (2002) Parkin accumulation in aggresomes due to proteasome impairment. J Biol Chem 277:47870\u201347877","journal-title":"J Biol Chem"},{"key":"486_CR126","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1091\/mbc.e03-02-0078","volume":"14","author":"HC Ardley","year":"2003","unstructured":"Ardley HC, Scott GB, Rose SA, Tan NG, Markham AF, Robinson PA (2003) Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing parkin. Mol Biol Cell 14:4541\u20134556","journal-title":"Mol Biol Cell"},{"key":"486_CR127","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1242\/jcs.00700","volume":"116","author":"J Zhao","year":"2003","unstructured":"Zhao J, Ren Y, Jiang Q, Feng J (2003) Parkin is recruited to the centrosome in response to inhibition of proteasomes. J Cell Sci 116:4011\u20134019","journal-title":"J Cell Sci"},{"key":"486_CR128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/hmg\/ddh012","volume":"13","author":"MM Muqit","year":"2004","unstructured":"Muqit MM, Davidson SM, Payne Smith MD, MacCormac LP, Kahns S, Jensen PH, Wood NW, Latchman DS (2004) Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin\u2019s effect on neuronal survival. Hum Mol Genet 13:117\u2013135","journal-title":"Hum Mol Genet"},{"key":"486_CR129","doi-asserted-by":"crossref","first-page":"12993","DOI":"10.1523\/JNEUROSCI.2860-08.2008","volume":"28","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, Ren Y, Feng J (2008) Direct binding with histone deacetylase 6 mediates the reversible recruitment of parkin to the centrosome. J Neurosci 28:12993\u201313002","journal-title":"J Neurosci"},{"key":"486_CR130","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1042\/BST0340749","volume":"34","author":"DJ Moore","year":"2006","unstructured":"Moore DJ (2006) Parkin: a multifaceted ubiquitin ligase. Biochem Soc Trans 34:749\u2013753","journal-title":"Biochem Soc Trans"},{"key":"486_CR131","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","volume":"115","author":"Y Kawaguchi","year":"2003","unstructured":"Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115:727\u2013738","journal-title":"Cell"},{"key":"486_CR132","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1083\/jcb.200611128","volume":"178","author":"JA Olzmann","year":"2007","unstructured":"Olzmann JA, Li L, Chudaev MV, Chen J, Perez FA, Palmiter RD, Chin LS (2007) Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J Cell Biol 178:1025\u20131038","journal-title":"J Cell Biol"},{"key":"486_CR133","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1471-4159.2009.06350.x","volume":"111","author":"T Kitada","year":"2009","unstructured":"Kitada T, Tong Y, Gautier CA, Shen J (2009) Absence of nigral degeneration in aged parkin\/DJ-1\/PINK1 triple knockout mice. J Neurochem 111:696\u2013702","journal-title":"J Neurochem"},{"key":"486_CR134","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1471-4159.2008.05607.x","volume":"107","author":"HQ Wang","year":"2008","unstructured":"Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N, Takahashi R (2008) Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss. J Neurochem 107:171\u2013185","journal-title":"J Neurochem"},{"key":"486_CR135","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1073\/pnas.0737556100","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA 100:4078\u20134083","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR136","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1073\/pnas.0501078102","volume":"102","author":"AJ Whitworth","year":"2005","unstructured":"Whitworth AJ, Theodore DA, Greene JC, Benes H, Wes PD, Pallanck LJ (2005) Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 102:8024\u20138029","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR137","doi-asserted-by":"crossref","first-page":"10345","DOI":"10.1073\/pnas.0500346102","volume":"102","author":"GH Cha","year":"2005","unstructured":"Cha GH, Kim S, Park J, Lee E, Kim M, Lee SB, Kim JM, Chung J, Cho KS (2005) Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci USA 102:10345\u201310350","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR138","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1073\/pnas.0709336105","volume":"105","author":"AC Poole","year":"2008","unstructured":"Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ (2008) The PINK1\/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA 105:1638\u20131643","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR139","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1073\/pnas.0803998105","volume":"105","author":"H Deng","year":"2008","unstructured":"Deng H, Dodson MW, Huang H, Guo M (2008) The Parkinson\u2019s disease genes PINK1 and parkin promote mitochondrial fission and\/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA 105:14503\u201314508","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10863-009-9253-3","volume":"41","author":"AJ Whitworth","year":"2009","unstructured":"Whitworth AJ, Pallanck LJ (2009) The PINK1\/Parkin pathway: a mitochondrial quality control system? J Bioenerg Biomembr 41:499\u2013503","journal-title":"J Bioenerg Biomembr"},{"key":"486_CR141","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ana.21492","volume":"64","author":"H Mortiboys","year":"2008","unstructured":"Mortiboys H, Thomas KJ, Koopman WJ et al (2008) Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol 64:555\u2013565","journal-title":"Ann Neurol"},{"key":"486_CR142","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1523\/JNEUROSCI.0218-07.2007","volume":"27","author":"C Wang","year":"2007","unstructured":"Wang C, Lu R, Ouyang X, Ho MW, Chia W, Yu F, Lim KL (2007) Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities. J Neurosci 27:8563\u20138570","journal-title":"J Neurosci"},{"key":"486_CR143","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1523\/JNEUROSCI.5351-08.2009","volume":"29","author":"XH Lu","year":"2009","unstructured":"Lu XH, Fleming SM, Meurers B et al (2009) Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. J Neurosci 29:1962\u20131976","journal-title":"J Neurosci"},{"key":"486_CR144","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183:795\u2013803","journal-title":"J Cell Biol"},{"key":"486_CR145","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/auto.5.5.8505","volume":"5","author":"D Narendra","year":"2009","unstructured":"Narendra D, Tanaka A, Suen DF, Youle RJ (2009) Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 5:706\u2013708","journal-title":"Autophagy"},{"key":"486_CR146","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1093\/hmg\/ddp384","volume":"18","author":"AK Berger","year":"2009","unstructured":"Berger AK, Cortese GP, Amodeo KD, Weihofen A, Letai A, LaVoie MJ (2009) Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Hum Mol Genet 18:4317\u20134328","journal-title":"Hum Mol Genet"},{"key":"486_CR147","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ncb1981","volume":"11","author":"CA da Costa","year":"2009","unstructured":"da Costa CA, Sunyach C, Giaime E et al (2009) Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson\u2019s disease. Nat Cell Biol 11:1370\u20131375","journal-title":"Nat Cell Biol"},{"key":"486_CR148","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1074\/jbc.M510926200","volume":"281","author":"H Jiang","year":"2006","unstructured":"Jiang H, Jiang Q, Liu W, Feng J (2006) Parkin suppresses the expression of monoamine oxidases. J Biol Chem 281:8591\u20138599","journal-title":"J Biol Chem"},{"key":"486_CR149","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1074\/jbc.M806245200","volume":"284","author":"Y Ren","year":"2009","unstructured":"Ren Y, Jiang H, Yang F, Nakaso K, Feng J (2009) Parkin protects dopaminergic neurons against microtubule-depolymerizing toxins by attenuating microtubule-associated protein kinase activation. J Biol Chem 284:4009\u20134017","journal-title":"J Biol Chem"},{"key":"486_CR150","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1471-4159.2008.05277.x","volume":"105","author":"T Hasegawa","year":"2008","unstructured":"Hasegawa T, Treis A, Patenge N, Fiesel FC, Springer W, Kahle PJ (2008) Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways. J Neurochem 105:1700\u20131715","journal-title":"J Neurochem"},{"key":"486_CR151","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","volume":"101","author":"S Hunot","year":"2004","unstructured":"Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 101:665\u2013670","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR152","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1441","volume":"8","author":"L Fallon","year":"2006","unstructured":"Fallon L, Belanger CM, Corera AT et al (2006) A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol 8:834\u2013842","journal-title":"Nat Cell Biol"},{"key":"486_CR153","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1073\/pnas.0606401103","volume":"103","author":"V Ries","year":"2006","unstructured":"Ries V, Henchcliffe C, Kareva T, Rzhetskaya M, Bland R, During MJ, Kholodilov N, Burke RE (2006) Oncoprotein Akt\/PKB induces trophic effects in murine models of Parkinson\u2019s disease. Proc Natl Acad Sci USA 103:18757\u201318762","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR154","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1523\/JNEUROSCI.5537-06.2007","volume":"27","author":"IH Henn","year":"2007","unstructured":"Henn IH, Bouman L, Schlehe JS et al (2007) Parkin mediates neuroprotection through activation of IkappaB kinase\/nuclear factor-kappaB signaling. J Neurosci 27:1868\u20131878","journal-title":"J Neurosci"},{"key":"486_CR155","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0896-6273(02)01125-X","volume":"36","author":"L Petrucelli","year":"2002","unstructured":"Petrucelli L, O\u2019Farrell C, Lockhart PJ et al (2002) Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36:1007\u20131019","journal-title":"Neuron"},{"key":"486_CR156","doi-asserted-by":"crossref","first-page":"41890","DOI":"10.1074\/jbc.M306017200","volume":"278","author":"SJ Kim","year":"2003","unstructured":"Kim SJ, Sung JY, Um JW, Hattori N, Mizuno Y, Tanaka K, Paik SR, Kim J, Chung KC (2003) Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain. J Biol Chem 278:41890\u201341899","journal-title":"J Biol Chem"},{"key":"486_CR157","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0896-6273(03)00143-0","volume":"37","author":"Y Yang","year":"2003","unstructured":"Yang Y, Nishimura I, Imai Y, Takahashi R, Lu B (2003) Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron 37:911\u2013924","journal-title":"Neuron"},{"key":"486_CR158","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.1073\/pnas.0405313101","volume":"101","author":"C Lo Bianco","year":"2004","unstructured":"Lo Bianco C, Schneider BL, Bauer M, Sajadi A, Brice A, Iwatsubo T, Aebischer P (2004) Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 101:17510\u201317515","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR159","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neulet.2006.03.001","volume":"401","author":"RL Klein","year":"2006","unstructured":"Klein RL, Dayton RD, Henderson KM, Petrucelli L (2006) Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model. Neurosci Lett 401:130\u2013135","journal-title":"Neurosci Lett"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-010-0486-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-010-0486-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-010-0486-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T18:41:16Z","timestamp":1559155276000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-010-0486-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,10]]},"references-count":159,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["486"],"URL":"https:\/\/doi.org\/10.1007\/s10495-010-0486-8","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,10]]}}}